728 x 90

Capital Grand Est’s game-changing investment in RDS sparks innovation revolution

Capital Grand Est’s game-changing investment in RDS sparks innovation revolution

RDS, a medical device start-up developing a Remote Patient Monitoring (RPM) solution called MultiSense, has secured €13 million in seed capital with the addition of Capital Grand Est to its investor pool. This funding will support the further development and market launch of MultiSense, as well as the initiation of marketing in Europe, the development of pipeline products, and new clinical trials. The company also plans to register the device with US authorities for a 2025 launch in the country. The support from Capital Grand Est and other investors confirms the appeal and potential of RDS’ technology, which has received backing from various organizations since its inception. MultiSense is a class IIa medical device that provides healthcare professionals with a comprehensive solution for continuous monitoring of patients’ health parameters. It combines a wearable patch with a cloud-based platform and delivers continuous measurements of six key parameters. The device is designed with sustainable development in mind, as it can be cleaned, refurbished, and reused to minimize its carbon footprint. The global remote patient monitoring market is expected to experience significant growth, driven by the adoption of short-term hospitalization protocols and the increasing eligibility for reimbursement of remote patient monitoring solutions.

Avatar of Nayan Kumar
Nayan Kumar
CONTRIBUTOR
PROFILE